← Back to Clinical Trials
Recruiting NCT07684417

NCT07684417 Impact of Short and Mistimed Sleep on Adolescents With ADHD: The Adolescent Attention and Circadian Timing Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07684417
Status Recruiting
Phase —
Sponsor Children's Hospital Medical Center, Cincinnati
Condition ADHD
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2026-07-10
Primary Completion 2030-08

Eligibility & Interventions

Sex All sexes
Min Age 13 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
Aligned sleep extensionMisaligned sleep extension

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2026-07-10 with a primary completion date of 2030-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Many adolescents go to bed late and wake up early for school. Science is only beginning to understand how sleep schedules can affect them. The investigators are interested in whether changing adolescents' sleep patterns affects their functioning, attention, and how they feel. The investigators are especially interested in the effects of changing both how much sleep adolescents get and when that sleep happens. This study focuses on healthy 13-17-year-olds with ADHD. This study asks adolescents to systematically change their sleeping habits across a 3 week span. The first week, they follow a sleep schedule that fits reasonably well with the schedule they keep when they do not have to wake up early for any specific obligation (e.g., for school). The second week, they spend several nights in a "short sleep" condition, during which they get 6.5 hours in bed per night. The final week, they enter a sleep condition that allows for healthy sleep duration, but with a timing that is randomly assigned to either fit well with their preferred schedule or fit poorly with that schedule. During each week, they and their parents complete measures of their attention and other factors. At the end of each week, they attend an evening session to measure their internal body clock ("circadian phase"), as well as measures of attention and other thinking skills. The goal is to understand whether the benefits of healthy sleep duration depend on the timing of when that sleep occurs.

Eligibility Criteria

Inclusion Criteria: * Ages 13-17 years at time of informed consent/assent * Based on semi-structured clinical interview, participants must meet full DSM-5 criteria for ADHD inattentive or ADHD combined presentation. Exclusion Criteria: * Non-traditional school setting (morning-afternoon Monday-Friday). * Exclusionary diagnoses. We will exclude adolescents with known intellectual disability, autism spectrum disorder, psychosis, bipolar disorder, or neurologic conditions (e.g., epilepsy), per caregiver-report. * Exclusionary sleep disorders. We will exclude adolescents with symptoms of obstructive sleep apnea or periodic limb movement disorder based on published cutoffs on a validated questionnaire. * High caffeine intake. To promote adherence to directives not to consume caffeine the day of office visits without withdrawal effects, adolescents with daily intake of \>1 coffee or "energy drink" or \>2 caffeinated sodas per day based on caregiver- and adolescent-report will be excluded. * Unwillingness or inability to take part in study procedures (e.g., visits, prescribed sleep conditions). * Medication use or unwillingness to discontinue melatonin and/or stimulant medications during the 3-week study protocol. * Refusal to refrain from automobile driving during the sleep restriction condition. * "Intermediate" Chronotypes (neither morning larks nor night owls) based on habitual sleep timing on nights when adolescent has no morning obligations such as school or work.

Contact & Investigator

Central Contact

Dean Beebe, Ph.D

✉ dean.beebe@cchmc.org

📞 513-636-3489

Principal Investigator

Dean Beebe, Ph.D.

PRINCIPAL INVESTIGATOR

Children's Hospital Medical Center, Cincinnati

Frequently Asked Questions

Who can join the NCT07684417 clinical trial?

This trial is open to participants of all sexes, aged 13 Years or older, up to 17 Years, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07684417 currently recruiting?

Yes, NCT07684417 is actively recruiting participants. Contact the research team at dean.beebe@cchmc.org for enrollment information.

Where is the NCT07684417 trial being conducted?

This trial is being conducted at Cincinnati, United States.

Who is sponsoring the NCT07684417 clinical trial?

NCT07684417 is sponsored by Children's Hospital Medical Center, Cincinnati. The principal investigator is Dean Beebe, Ph.D. at Children's Hospital Medical Center, Cincinnati. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology